000 01299 a2200361 4500
005 20250516130441.0
264 0 _c20130709
008 201307s 0 0 eng d
022 _a1873-264X
024 7 _a10.1016/j.jpba.2012.11.032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzyrwiel, Lukasz
245 0 0 _aInteractions of anti-Parkinson drug benserazide with Zn(II), Cu(II), Fe(II) ions.
_h[electronic resource]
260 _bJournal of pharmaceutical and biomedical analysis
_cMar 2013
300 _a36-43 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntiparkinson Agents
_xpharmacology
650 0 4 _aBenserazide
_xpharmacology
650 0 4 _aCopper
_xmetabolism
650 0 4 _aDrug Combinations
650 0 4 _aIron
_xmetabolism
650 0 4 _aLevodopa
_xpharmacology
650 0 4 _aMass Spectrometry
_xmethods
650 0 4 _aSpectrophotometry, Ultraviolet
_xmethods
650 0 4 _aZinc
_xmetabolism
700 1 _aPap, József S
700 1 _aMalinka, Wieslaw
700 1 _aSzewczuk, Zbigniew
700 1 _aKotynia, Aleksandra
700 1 _aBrasun, Justyna
773 0 _tJournal of pharmaceutical and biomedical analysis
_gvol. 76
_gp. 36-43
856 4 0 _uhttps://doi.org/10.1016/j.jpba.2012.11.032
_zAvailable from publisher's website
999 _c22394969
_d22394969